U.S. Markets closed
LISTEN

Schultz: Businesses need to do more to help people

Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz

Nymox Pharmaceutical Corporation (NYMX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
3.89+0.06 (+1.57%)
At close: 4:00PM EDT
People also watch
SPHSEBIOPBMDNVGNCYCC
Full screen
Previous Close3.83
Open3.80
Bid3.25 x 200
Ask4.19 x 100
Day's Range3.80 - 3.96
52 Week Range2.67 - 5.10
Volume57,938
Avg. Volume177,326
Market Cap203.71M
Beta1.36
PE Ratio (TTM)-16.55
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube11 days ago

    ETFs with exposure to Nymox Pharmaceutical Corp. : September 12, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Nymox Pharmaceutical Corp. Here are 5 ETFs with the largest exposure to NYMX-US. Comparing the performance and risk of Nymox Pharmaceutical Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube23 days ago

    ETFs with exposure to Nymox Pharmaceutical Corp. : August 31, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Nymox Pharmaceutical Corp. Here are 5 ETFs with the largest exposure to NYMX-US. Comparing the performance and risk of Nymox Pharmaceutical Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Nymox Pharmaceutical Corp. :NYMX-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017
    Capital Cubelast month

    Nymox Pharmaceutical Corp. :NYMX-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017

    Categories: Yahoo FinanceGet free summary analysis Nymox Pharmaceutical Corp. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Nymox Pharmaceutical Corp. – Abbott Laboratories, Eli Lilly and Company, Quest Diagnostics Incorporated, Pfizer Inc., Johnson & Johnson and Sophiris Bio Inc. (ABT-US, LLY-US, DGX-US, PFE-US, JNJ-US and ... Read more (Read more...)